Beta thalassemia (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Beta thalassemia" in English language version.

refsWebsite

Global rank English rank

67nih.gov

4^th place

35doi.org

2^nd place

19web.archive.org

1^st place

12books.google.com

3^rd place

4nhs.uk

1,989^th place

1,528^th place

2medscape.com

719^th place

636^th place

2archive.org

6^th place

2hopkinsmedicine.org

5,712^th place

3,986^th place

2england.nhs.uk

low place

2gov.uk

432^nd place

278^th place

2mayoclinic.org

1,610^th place

1,279^th place

2semanticscholar.org

11^th place

8^th place

2worldcat.org

5^th place

2fda.gov

447^th place

338^th place

1swbh.nhs.uk

low place

1wales.nhs.uk

low place

1harvard.edu

18^th place

17^th place

1omim.org

4,380^th place

4,305^th place

1elsevier.com

610^th place

704^th place

1uptodate.com

3,771^st place

2,605^th place

1medlineplus.gov

1,581^st place

1,299^th place

1acog.org

low place

8,531^st place

1hoacny.com

low place

1cdc.gov

218^th place

212^th place

1thalassemia.org

low place

1patient.info

low place

7,180^th place

1clevelandclinic.org

4,925^th place

3,597^th place

1ucsf.edu

5,479^th place

3,911^th place

1science.org

1,160^th place

737^th place

1crisprtx.com

low place

1npr.org

92^nd place

72^nd place

1casgevy.com

low place

1wa.gov

2,121^st place

1,217^th place

1msdmanuals.com

4,047^th place

8,904^th place

1etymonline.com

287^th place

321^st place

1tufts.edu

155^th place

138^th place

1who.int

195^th place

302^nd place

1accessmedicine.com

low place

accessmedicine.com

Weatherall DJ (2010). "The Thalassemias: Disorders of Globin Synthesis". In Lichtman MA, Kipps TJ, Seligsohn U, Kaushansky K, Prchal JT (eds.). Williams Hematology (8th ed.). The McGraw-Hill Companies. Archived from the original on 2013-11-04. Retrieved 2012-10-02.

acog.org

"Carrier Screening for Hemoglobinopathies: Sickle Cell Disease and Thalassemia". American College of Obstetricians and Gynecologists. October 2022. Retrieved 21 February 2025.

archive.org

Lanzkowsky's Manual Of Pediatric Hematology And Oncology 6th Edition ( 2016).
Lippincott Williams & Wilkins (2009). Professional Guide to Diseases. Lippincott Williams & Wilkins. ISBN 978-0-7817-7899-2. OCLC 175284310.

books.google.com

McKinney ES, James SR, Murray SS, Nelson K, Ashwill J (2014-04-17). Maternal-Child Nursing. Elsevier Health Sciences. ISBN 978-0-323-29377-8. Archived from the original on 2023-01-14. Retrieved 2020-10-25.
Goldman L, Schafer AI (2015-04-21). Goldman-Cecil Medicine: Expert Consult — Online. Elsevier Health Sciences. ISBN 978-0-323-32285-0.
Carton J (2012-02-16). Oxford Handbook of Clinical Pathology. OUP Oxford. ISBN 978-0-19-162993-8. Archived from the original on 2023-01-14. Retrieved 2020-10-25.
Introduction to Pathology for the Physical Therapist Assistant. Jones & Bartlett Publishers. 2011. ISBN 978-0-7637-9908-3. Archived from the original on 2023-01-14. Retrieved 2020-10-25.
Leonard DG (2007-11-25). Molecular Pathology in Clinical Practice. Springer. ISBN 978-0-387-33227-7. Archived from the original on 2023-01-14. Retrieved 2020-10-25.
Bowen JM, Mazzaferri EL (2012-12-06). Contemporary Internal Medicine: Clinical Case Studies. Springer. ISBN 978-1-4615-6713-4.
National Organization for Rare Disorders (2003). NORD Guide to Rare Disorders. Lippincott Williams & Wilkins. ISBN 978-0-7817-3063-1. Archived from the original on 2023-01-14. Retrieved 2020-10-25.
Barton JC, Edwards CQ (2000-01-13). Hemochromatosis: Genetics, Pathophysiology, Diagnosis and Treatment. Cambridge University Press. ISBN 978-0-521-59380-9. Archived from the original on 2023-01-14. Retrieved 2020-10-25.
Kottke-Marchant K, Davis B (2012). Laboratory Hematology Practice (1st ed.). John Wiley & Sons. p. 569. ISBN 978-1-4443-9857-1.
Pal GK (2005). Textbook Of Practical Physiology (2nd ed.). Orient Blackswan. p. 53. ISBN 9788125029045. Retrieved 17 September 2016.
Berg S, Bittner EA (2013-10-16). The MGH Review of Critical Care Medicine. Lippincott Williams & Wilkins. ISBN 978-1-4511-7368-0.
Abouelmagd A, Ageely HM (2013). Basic Genetics: A Primer Covering Molecular Composition of Genetic Material, Gene Expression and Genetic Engineering, and Mutations and Human Genetic. Universal-Publishers. ISBN 978-1-61233-192-8. Archived from the original on 2023-01-14. Retrieved 2020-10-25.

casgevy.com

"Patient Information | CASGEVY® (exagamglogene autotemcel)". www.casgevy.com. Archived from the original on 2024-12-02. Retrieved 2025-01-20.

cdc.gov

CDC (2025-01-02). "Treatment of Thalassemia". Thalassemia. Retrieved 2025-01-15.

clevelandclinic.org

my.clevelandclinic.org

"Hematopoiesis". Cleveland Clinic. December 12, 2022. Retrieved 6 December 2024.

crisprtx.com

ir.crisprtx.com

"CRISPR Therapeutics Announces U.S. Food and Drug Administration (FDA) Approval of CASGEVY™ (exagamglogene autotemcel) for the Treatment of Transfusion-Dependent Beta Thalassemia". CRISPR Therapeutics. 14 Jan 2024. Retrieved 20 January 2025.

doi.org

Galanello R, Origa R (May 2010). "Beta-thalassemia". Orphanet Journal of Rare Diseases. 5: 11. doi:10.1186/1750-1172-5-11. PMC 2893117. PMID 20492708.
Fattoum S (10 November 2009). "Evolution of hemoglobinopathy prevention in Africa: results, problems and prospect". Mediterranean Journal of Hematology and Infectious Diseases. pp. e2009005. doi:10.4084/MJHID.2009.005.
Kattamis A, Forni GL, Aydinok Y, Viprakasit V (December 2020). "Changing patterns in the epidemiology of β-thalassemia". European Journal of Haematology. pp. 692–703. doi:10.1111/ejh.13512.
Kattamis A, Kwiatkowski JL, Aydinok Y (June 2022). "Thalassaemia". Lancet. 399 (10343): 2310–2324. doi:10.1016/S0140-6736(22)00536-0. PMID 35691301.
Harteveld CL, Higgs DR (May 2010). "Alpha-thalassaemia". Orphanet Journal of Rare Diseases. 5 (1): 13. doi:10.1186/1750-1172-5-13. PMC 2887799. PMID 20507641.
Rao E, Kumar Chandraker S, Misha Singh M, Kumar R (February 2024). "Global distribution of β-thalassemia mutations: An update". Gene. 896: 148022. doi:10.1016/j.gene.2023.148022. PMID 38007159.
Taher AT, Musallam KM, Cappellini MD (February 2021). "β-Thalassemias". The New England Journal of Medicine. 384 (8): 727–743. doi:10.1056/NEJMra2021838. PMID 33626255. S2CID 232049825.
Angoro B, Motshakeri M, Hemmaway C, Svirskis D, Sharma M (June 2022). "Non-transferrin bound iron". Clinica Chimica Acta; International Journal of Clinical Chemistry. 531: 157–167. doi:10.1016/j.cca.2022.04.004. PMID 35398023.
Saliba AN, Musallam KM, Taher AT (September 2023). "How I treat non-transfusion-dependent β-thalassemia". Blood. 142 (11): 949–960. doi:10.1182/blood.2023020683. PMC 10644094. PMID 37478396.
Thein SL (May 2013). "The molecular basis of β-thalassemia". Cold Spring Harbor Perspectives in Medicine. 3 (5): a011700. doi:10.1101/cshperspect.a011700. PMC 3633182. PMID 23637309.
Paulson RF, Hariharan S, Little JA (2020-09-01). "Stress erythropoiesis: definitions and models for its study". Experimental Hematology. 89: 43–54.e2. doi:10.1016/j.exphem.2020.07.011. ISSN 0301-472X. PMC 7508762. PMID 32750404.
Khera R, Singh T, Khuana N, Gupta N, Dubey AP (March 2015). "HPLC in characterization of hemoglobin profile in thalassemia syndromes and hemoglobinopathies: a clinicohematological correlation". Indian Journal of Hematology & Blood Transfusion. 31 (1): 110–115. doi:10.1007/s12288-014-0409-x. PMC 4275515. PMID 25548455.
Munkongdee T, Chen P, Winichagoon P, Fucharoen S, Paiboonsukwong K (2020-05-27). "Update in Laboratory Diagnosis of Thalassemia". Frontiers in Molecular Biosciences. 7: 74. doi:10.3389/fmolb.2020.00074. PMC 7326097. PMID 32671092.
Hussein N, Henneman L, Kai J, Qureshi N, et al. (Cochrane Cystic Fibrosis and Genetic Disorders Group) (October 2021). "Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease". The Cochrane Database of Systematic Reviews. 10 (10): CD010849. doi:10.1002/14651858.CD010849.pub4. PMC 8504980. PMID 34634131.
Leung TN, Lau TK, Chung TK (April 2005). "Thalassaemia screening in pregnancy". Current Opinion in Obstetrics & Gynecology. 17 (2): 129–134. doi:10.1097/01.gco.0000162180.22984.a3. PMID 15758603. S2CID 41877258.
Cousens NE, Gaff CL, Metcalfe SA, Delatycki MB (October 2010). "Carrier screening for beta-thalassaemia: a review of international practice". European Journal of Human Genetics. 18 (10): 1077–1083. doi:10.1038/ejhg.2010.90. PMC 2987452. PMID 20571509.
Samavat A, Modell B (November 2004). "Iranian national thalassaemia screening programme". BMJ. 329 (7475): 1134–1137. doi:10.1136/bmj.329.7475.1134. PMC 527686. PMID 15539666.
Petrou M (January 2010). "Screening for beta thalassaemia". Indian Journal of Human Genetics. 16 (1): 1–5. doi:10.4103/0971-6866.64934. PMC 2927788. PMID 20838484.
Neufeld EJ (2010). "Update on iron chelators in thalassemia". Hematology. American Society of Hematology. Education Program. 2010: 451–455. doi:10.1182/asheducation-2010.1.451. PMID 21239834.
Cappellini MD, Taher AT (January 2021). "The use of luspatercept for thalassemia in adults". Blood Advances. 5 (1): 326–333. doi:10.1182/bloodadvances.2020002725. PMC 7805339. PMID 33570654.
Banan M (March 2013). "Hydroxyurea treatment in β-thalassemia patients: to respond or not to respond?". Annals of Hematology. 92 (3): 289–299. doi:10.1007/s00277-012-1671-3. PMID 23318979.
Ansari SH, Lassi ZS, Khowaja SM, Adil SO, Shamsi TS, et al. (Cochrane Cystic Fibrosis and Genetic Disorders Group) (March 2019). "Hydroxyurea (hydroxycarbamide) for transfusion-dependent β-thalassaemia". The Cochrane Database of Systematic Reviews. 3 (3): CD012064. doi:10.1002/14651858.CD012064.pub2. PMC 6421980. PMID 30882896.
Bhardwaj A, Swe KM, Sinha NK (May 2023). "Treatment for osteoporosis in people with beta-thalassaemia". The Cochrane Database of Systematic Reviews. 5 (5): CD010429. doi:10.1002/14651858.CD010429.pub3. PMC 10167785. PMID 37159055.
Olson TS, Walters MC (October 2023). "Allogeneic haematopoietic stem-cell transplantation versus gene therapy for haemoglobinopathies". The Lancet. Haematology. 10 (10): e798 – e800. doi:10.1016/S2352-3026(23)00246-6. PMID 37793770.
Lucarelli G, Isgrò A, Sodani P, Gaziev J (May 2012). "Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia". Cold Spring Harbor Perspectives in Medicine. 2 (5): a011825. doi:10.1101/cshperspect.a011825. PMC 3331690. PMID 22553502.
Angelucci E, Pilo F, Targhetta C, Pettinau M, Depau C, Cogoni C, et al. (December 2009). "Hematopietic stem cell transplantation in thalassemia and related disorders". Mediterranean Journal of Hematology and Infectious Diseases. 1 (1): e2009015. doi:10.4084/MJHID.2009.015. PMC 3033161. PMID 21415993.
Rotin LE, Viswabandya A, Kumar R, Patriquin CJ, Kuo KH (December 2023). "A systematic review comparing allogeneic hematopoietic stem cell transplant to gene therapy in sickle cell disease". Hematology. 28 (1): 2163357. doi:10.1080/16078454.2022.2163357. PMID 36728286.
Sodani P, Isgrò A, Gaziev J, Paciaroni K, Marziali M, Simone MD, et al. (June 2011). "T cell-depleted hla-haploidentical stem cell transplantation in thalassemia young patients". Pediatric Reports. 3 Suppl 2 (Suppl 2): e13. doi:10.4081/pr.2011.s2.e13. PMC 3206538. PMID 22053275.
Ribeil JA, Hacein-Bey-Abina S, Payen E, Magnani A, Semeraro M, Magrin E, et al. (March 2017). "Gene Therapy in a Patient with Sickle Cell Disease". The New England Journal of Medicine. 376 (9): 848–855. doi:10.1056/NEJMoa1609677. PMID 28249145.
Biffi A (April 2018). "Gene Therapy as a Curative Option for β-Thalassemia". The New England Journal of Medicine. 378 (16): 1551–1552. doi:10.1056/NEJMe1802169. PMID 29669229.
Negre O, Eggimann AV, Beuzard Y, Ribeil JA, Bourget P, Borwornpinyo S, et al. (February 2016). "Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene". Human Gene Therapy. 27 (2): 148–165. doi:10.1089/hum.2016.007. PMC 4779296. PMID 26886832.
Khatri G, Sahito AM, Ansari SA (December 2021). "Shared molecular basis, diagnosis, and co-inheritance of alpha and beta thalassemia". Blood Research. 56 (4): 332–333. doi:10.5045/br.2021.2021128. PMC 8721464. PMID 34776416.
Wambua S, Mwacharo J, Uyoga S, Macharia A, Williams TN (April 2006). "Co-inheritance of alpha+-thalassaemia and sickle trait results in specific effects on haematological parameters". British Journal of Haematology. 133 (2): 206–209. doi:10.1111/j.1365-2141.2006.06006.x. PMC 4394356. PMID 16611313.
Torres L, Okumura JV, Silva DG, Bonini-Domingos CR (March 2015). "Hemoglobin D-Punjab: origin, distribution and laboratory diagnosis". Revista Brasileira De Hematologia E Hemoterapia. 37 (2): 120–126. doi:10.1016/j.bjhh.2015.02.007. PMC 4382585. PMID 25818823.
Olivieri NF, Muraca GM, O'Donnell A, Premawardhena A, Fisher C, Weatherall DJ (May 2008). "Studies in haemoglobin E beta-thalassaemia". British Journal of Haematology. 141 (3): 388–397. doi:10.1111/j.1365-2141.2008.07126.x. PMID 18410572.

elsevier.com

linkinghub.elsevier.com

Paulson RF, Hariharan S, Little JA (2020-09-01). "Stress erythropoiesis: definitions and models for its study". Experimental Hematology. 89: 43–54.e2. doi:10.1016/j.exphem.2020.07.011. ISSN 0301-472X. PMC 7508762. PMID 32750404.

england.nhs.uk

"Clinical commissioning policy: allogeneic haematopoietic stem cell transplantation (Allo-HSCT) for adult transfusion dependent thalassaemia". NHS England. 2023-11-10. Retrieved 2025-01-18.
"NHS England » Clinical commissioning policy: allogeneic haematopoietic stem cell transplantation (Allo-HSCT) for adult transfusion dependent thalassaemia". www.england.nhs.uk. 2023-11-10. Retrieved 2025-01-18.

etymonline.com

Harper D. "thalassemia". Online Etymology Dictionary.

fda.gov

"Zynteglo". U.S. Food and Drug Administration. 17 August 2022. Archived from the original on 26 August 2022. Retrieved 26 August 2022.
"FDA Approves First Cell-Based Gene Therapy to Treat Adult and Pediatric Patients with Beta-thalassemia Who Require Regular Blood Transfusions". U.S. Food and Drug Administration (FDA) (Press release). 17 August 2022. Archived from the original on 21 August 2022. Retrieved 20 August 2022. This article incorporates text from this source, which is in the public domain.

gov.uk

"MHRA authorises world-first gene therapy that aims to cure sickle-cell disease and transfusion-dependent β-thalassemia". Medicines and Healthcare products Regulatory Agency (MHRA) (Press release). 16 November 2023. Archived from the original on 25 November 2023. Retrieved 8 December 2023.
"MHRA authorises world-first gene therapy that aims to cure sickle-cell disease and transfusion-dependent β-thalassemia". Medicines and Healthcare products Regulatory Agency (MHRA) (Press release). 16 November 2023. Archived from the original on 25 November 2023. Retrieved 8 December 2023.

harvard.edu

sickle.bwh.harvard.edu

"Hemoglobinopathies". Brigham and Women's Hospital. 17 April 2002. Retrieved 2009-02-06.

hoacny.com

"Treatment of Thalassemias". Hematology-Oncology Associates of CNY. 2018-01-25. Retrieved 2025-01-17.

hopkinsmedicine.org

"Beta Thalassemia". Johns Hopkins Medicine. Archived from the original on 2025-01-25. Retrieved 2025-02-18.
"Alpha Thalassemia". Johns Hopkins Medicine. 27 January 2025. Retrieved 27 January 2025.

mayoclinic.org

"Thalassemia-Thalassemia - Symptoms & causes". Mayo Clinic. 17 Nov 2021. Retrieved 2025-01-07.
"Risk Factors". Mayo Clinic. Archived from the original on 20 November 2016. Retrieved 4 April 2017.

medlineplus.gov

"Hemoglobin Electrophoresis: MedlinePlus Medical Test". medlineplus.gov. Retrieved 2024-11-20.

medscape.com

emedicine.medscape.com

Advani P. "Beta Thalassemia Treatment & Management". Medscape. Archived from the original on 4 April 2017. Retrieved 4 April 2017.
Pediatric Thalassemia~treatment at eMedicine

msdmanuals.com

Gerber GF (April 2024). "Hemoglobin S–Beta-Thalassemia Disease - Hematology and Oncology". MSD Manual Professional Edition. Retrieved 2024-12-24.

nhs.uk

"Thalassaemia - Thalassaemia carriers". National Health Service. 17 October 2022. Retrieved 2025-01-27.
"Newborn blood spot test". National Health Service. 5 September 2024. Retrieved 2024-11-20.
"Thalassaemia - Treatment". nhs.uk. 17 October 2022. Retrieved 2025-01-15.
"Stem cell transplant - What happens". nhs.uk. 2017-10-23. Retrieved 2024-12-07.

nih.gov

pubmed.ncbi.nlm.nih.gov

Galanello R, Origa R (May 2010). "Beta-thalassemia". Orphanet Journal of Rare Diseases. 5: 11. doi:10.1186/1750-1172-5-11. PMC 2893117. PMID 20492708.
Bajwa H, Basit H (2025). "Thalassemia". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 31424735. Retrieved 2025-02-18.
Kattamis A, Kwiatkowski JL, Aydinok Y (June 2022). "Thalassaemia". Lancet. 399 (10343): 2310–2324. doi:10.1016/S0140-6736(22)00536-0. PMID 35691301.
Langer AL (8 February 2024). "Beta-Thalassemia". In Adam MP, Feldman J, Mirzaa GM (eds.). GeneReviews®. University of Washington, Seattle. PMID 20301599. Retrieved 2025-02-18.
Harteveld CL, Higgs DR (May 2010). "Alpha-thalassaemia". Orphanet Journal of Rare Diseases. 5 (1): 13. doi:10.1186/1750-1172-5-13. PMC 2887799. PMID 20507641.
Rao E, Kumar Chandraker S, Misha Singh M, Kumar R (February 2024). "Global distribution of β-thalassemia mutations: An update". Gene. 896: 148022. doi:10.1016/j.gene.2023.148022. PMID 38007159.
Taher AT, Musallam KM, Cappellini MD (February 2021). "β-Thalassemias". The New England Journal of Medicine. 384 (8): 727–743. doi:10.1056/NEJMra2021838. PMID 33626255. S2CID 232049825.
Angoro B, Motshakeri M, Hemmaway C, Svirskis D, Sharma M (June 2022). "Non-transferrin bound iron". Clinica Chimica Acta; International Journal of Clinical Chemistry. 531: 157–167. doi:10.1016/j.cca.2022.04.004. PMID 35398023.
Saliba AN, Musallam KM, Taher AT (September 2023). "How I treat non-transfusion-dependent β-thalassemia". Blood. 142 (11): 949–960. doi:10.1182/blood.2023020683. PMC 10644094. PMID 37478396.
Thein SL (May 2013). "The molecular basis of β-thalassemia". Cold Spring Harbor Perspectives in Medicine. 3 (5): a011700. doi:10.1101/cshperspect.a011700. PMC 3633182. PMID 23637309.
Paulson RF, Hariharan S, Little JA (2020-09-01). "Stress erythropoiesis: definitions and models for its study". Experimental Hematology. 89: 43–54.e2. doi:10.1016/j.exphem.2020.07.011. ISSN 0301-472X. PMC 7508762. PMID 32750404.
Bajwa H, Basit H (August 2023). "Thalassemia". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 31424735. Retrieved 2025-01-13.
Harewood J, Azevedo AM (4 September 2023). "Alpha Thalassemia". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 28722856. Retrieved 2025-01-13.
Khera R, Singh T, Khuana N, Gupta N, Dubey AP (March 2015). "HPLC in characterization of hemoglobin profile in thalassemia syndromes and hemoglobinopathies: a clinicohematological correlation". Indian Journal of Hematology & Blood Transfusion. 31 (1): 110–115. doi:10.1007/s12288-014-0409-x. PMC 4275515. PMID 25548455.
Munkongdee T, Chen P, Winichagoon P, Fucharoen S, Paiboonsukwong K (2020-05-27). "Update in Laboratory Diagnosis of Thalassemia". Frontiers in Molecular Biosciences. 7: 74. doi:10.3389/fmolb.2020.00074. PMC 7326097. PMID 32671092.
Hussein N, Henneman L, Kai J, Qureshi N, et al. (Cochrane Cystic Fibrosis and Genetic Disorders Group) (October 2021). "Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease". The Cochrane Database of Systematic Reviews. 10 (10): CD010849. doi:10.1002/14651858.CD010849.pub4. PMC 8504980. PMID 34634131.
Leung TN, Lau TK, Chung TK (April 2005). "Thalassaemia screening in pregnancy". Current Opinion in Obstetrics & Gynecology. 17 (2): 129–134. doi:10.1097/01.gco.0000162180.22984.a3. PMID 15758603. S2CID 41877258.
Cousens NE, Gaff CL, Metcalfe SA, Delatycki MB (October 2010). "Carrier screening for beta-thalassaemia: a review of international practice". European Journal of Human Genetics. 18 (10): 1077–1083. doi:10.1038/ejhg.2010.90. PMC 2987452. PMID 20571509.
Loukopoulos D (October 2011). "Haemoglobinopathies in Greece: prevention programme over the past 35 years". The Indian Journal of Medical Research. 134 (4): 572–576. PMC 3237258. PMID 22089622.
Samavat A, Modell B (November 2004). "Iranian national thalassaemia screening programme". BMJ. 329 (7475): 1134–1137. doi:10.1136/bmj.329.7475.1134. PMC 527686. PMID 15539666.
Petrou M (January 2010). "Screening for beta thalassaemia". Indian Journal of Human Genetics. 16 (1): 1–5. doi:10.4103/0971-6866.64934. PMC 2927788. PMID 20838484.
Neufeld EJ (2010). "Update on iron chelators in thalassemia". Hematology. American Society of Hematology. Education Program. 2010: 451–455. doi:10.1182/asheducation-2010.1.451. PMID 21239834.
Cappellini MD, Taher AT (January 2021). "The use of luspatercept for thalassemia in adults". Blood Advances. 5 (1): 326–333. doi:10.1182/bloodadvances.2020002725. PMC 7805339. PMID 33570654.
Banan M (March 2013). "Hydroxyurea treatment in β-thalassemia patients: to respond or not to respond?". Annals of Hematology. 92 (3): 289–299. doi:10.1007/s00277-012-1671-3. PMID 23318979.
Ansari SH, Lassi ZS, Khowaja SM, Adil SO, Shamsi TS, et al. (Cochrane Cystic Fibrosis and Genetic Disorders Group) (March 2019). "Hydroxyurea (hydroxycarbamide) for transfusion-dependent β-thalassaemia". The Cochrane Database of Systematic Reviews. 3 (3): CD012064. doi:10.1002/14651858.CD012064.pub2. PMC 6421980. PMID 30882896.
Bhardwaj A, Swe KM, Sinha NK (May 2023). "Treatment for osteoporosis in people with beta-thalassaemia". The Cochrane Database of Systematic Reviews. 5 (5): CD010429. doi:10.1002/14651858.CD010429.pub3. PMC 10167785. PMID 37159055.
Olson TS, Walters MC (October 2023). "Allogeneic haematopoietic stem-cell transplantation versus gene therapy for haemoglobinopathies". The Lancet. Haematology. 10 (10): e798 – e800. doi:10.1016/S2352-3026(23)00246-6. PMID 37793770.
Lucarelli G, Isgrò A, Sodani P, Gaziev J (May 2012). "Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia". Cold Spring Harbor Perspectives in Medicine. 2 (5): a011825. doi:10.1101/cshperspect.a011825. PMC 3331690. PMID 22553502.
Angelucci E, Pilo F, Targhetta C, Pettinau M, Depau C, Cogoni C, et al. (December 2009). "Hematopietic stem cell transplantation in thalassemia and related disorders". Mediterranean Journal of Hematology and Infectious Diseases. 1 (1): e2009015. doi:10.4084/MJHID.2009.015. PMC 3033161. PMID 21415993.
Rotin LE, Viswabandya A, Kumar R, Patriquin CJ, Kuo KH (December 2023). "A systematic review comparing allogeneic hematopoietic stem cell transplant to gene therapy in sickle cell disease". Hematology. 28 (1): 2163357. doi:10.1080/16078454.2022.2163357. PMID 36728286.
Sodani P, Isgrò A, Gaziev J, Paciaroni K, Marziali M, Simone MD, et al. (June 2011). "T cell-depleted hla-haploidentical stem cell transplantation in thalassemia young patients". Pediatric Reports. 3 Suppl 2 (Suppl 2): e13. doi:10.4081/pr.2011.s2.e13. PMC 3206538. PMID 22053275.
Ribeil JA, Hacein-Bey-Abina S, Payen E, Magnani A, Semeraro M, Magrin E, et al. (March 2017). "Gene Therapy in a Patient with Sickle Cell Disease". The New England Journal of Medicine. 376 (9): 848–855. doi:10.1056/NEJMoa1609677. PMID 28249145.
Biffi A (April 2018). "Gene Therapy as a Curative Option for β-Thalassemia". The New England Journal of Medicine. 378 (16): 1551–1552. doi:10.1056/NEJMe1802169. PMID 29669229.
Negre O, Eggimann AV, Beuzard Y, Ribeil JA, Bourget P, Borwornpinyo S, et al. (February 2016). "Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene". Human Gene Therapy. 27 (2): 148–165. doi:10.1089/hum.2016.007. PMC 4779296. PMID 26886832.
Khatri G, Sahito AM, Ansari SA (December 2021). "Shared molecular basis, diagnosis, and co-inheritance of alpha and beta thalassemia". Blood Research. 56 (4): 332–333. doi:10.5045/br.2021.2021128. PMC 8721464. PMID 34776416.
Wambua S, Mwacharo J, Uyoga S, Macharia A, Williams TN (April 2006). "Co-inheritance of alpha+-thalassaemia and sickle trait results in specific effects on haematological parameters". British Journal of Haematology. 133 (2): 206–209. doi:10.1111/j.1365-2141.2006.06006.x. PMC 4394356. PMID 16611313.
Torres L, Okumura JV, Silva DG, Bonini-Domingos CR (March 2015). "Hemoglobin D-Punjab: origin, distribution and laboratory diagnosis". Revista Brasileira De Hematologia E Hemoterapia. 37 (2): 120–126. doi:10.1016/j.bjhh.2015.02.007. PMC 4382585. PMID 25818823.
Olivieri NF, Muraca GM, O'Donnell A, Premawardhena A, Fisher C, Weatherall DJ (May 2008). "Studies in haemoglobin E beta-thalassaemia". British Journal of Haematology. 141 (3): 388–397. doi:10.1111/j.1365-2141.2008.07126.x. PMID 18410572.

ncbi.nlm.nih.gov

Galanello R, Origa R (May 2010). "Beta-thalassemia". Orphanet Journal of Rare Diseases. 5: 11. doi:10.1186/1750-1172-5-11. PMC 2893117. PMID 20492708.
Bajwa H, Basit H (2025). "Thalassemia". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 31424735. Retrieved 2025-02-18.
Langer AL (8 February 2024). "Beta-Thalassemia". In Adam MP, Feldman J, Mirzaa GM (eds.). GeneReviews®. University of Washington, Seattle. PMID 20301599. Retrieved 2025-02-18.
Harteveld CL, Higgs DR (May 2010). "Alpha-thalassaemia". Orphanet Journal of Rare Diseases. 5 (1): 13. doi:10.1186/1750-1172-5-13. PMC 2887799. PMID 20507641.
Saliba AN, Musallam KM, Taher AT (September 2023). "How I treat non-transfusion-dependent β-thalassemia". Blood. 142 (11): 949–960. doi:10.1182/blood.2023020683. PMC 10644094. PMID 37478396.
Thein SL (May 2013). "The molecular basis of β-thalassemia". Cold Spring Harbor Perspectives in Medicine. 3 (5): a011700. doi:10.1101/cshperspect.a011700. PMC 3633182. PMID 23637309.
Paulson RF, Hariharan S, Little JA (2020-09-01). "Stress erythropoiesis: definitions and models for its study". Experimental Hematology. 89: 43–54.e2. doi:10.1016/j.exphem.2020.07.011. ISSN 0301-472X. PMC 7508762. PMID 32750404.
Bajwa H, Basit H (August 2023). "Thalassemia". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 31424735. Retrieved 2025-01-13.
Harewood J, Azevedo AM (4 September 2023). "Alpha Thalassemia". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 28722856. Retrieved 2025-01-13.
Khera R, Singh T, Khuana N, Gupta N, Dubey AP (March 2015). "HPLC in characterization of hemoglobin profile in thalassemia syndromes and hemoglobinopathies: a clinicohematological correlation". Indian Journal of Hematology & Blood Transfusion. 31 (1): 110–115. doi:10.1007/s12288-014-0409-x. PMC 4275515. PMID 25548455.
Munkongdee T, Chen P, Winichagoon P, Fucharoen S, Paiboonsukwong K (2020-05-27). "Update in Laboratory Diagnosis of Thalassemia". Frontiers in Molecular Biosciences. 7: 74. doi:10.3389/fmolb.2020.00074. PMC 7326097. PMID 32671092.
Hussein N, Henneman L, Kai J, Qureshi N, et al. (Cochrane Cystic Fibrosis and Genetic Disorders Group) (October 2021). "Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease". The Cochrane Database of Systematic Reviews. 10 (10): CD010849. doi:10.1002/14651858.CD010849.pub4. PMC 8504980. PMID 34634131.
Cousens NE, Gaff CL, Metcalfe SA, Delatycki MB (October 2010). "Carrier screening for beta-thalassaemia: a review of international practice". European Journal of Human Genetics. 18 (10): 1077–1083. doi:10.1038/ejhg.2010.90. PMC 2987452. PMID 20571509.
Loukopoulos D (October 2011). "Haemoglobinopathies in Greece: prevention programme over the past 35 years". The Indian Journal of Medical Research. 134 (4): 572–576. PMC 3237258. PMID 22089622.
Samavat A, Modell B (November 2004). "Iranian national thalassaemia screening programme". BMJ. 329 (7475): 1134–1137. doi:10.1136/bmj.329.7475.1134. PMC 527686. PMID 15539666.
Petrou M (January 2010). "Screening for beta thalassaemia". Indian Journal of Human Genetics. 16 (1): 1–5. doi:10.4103/0971-6866.64934. PMC 2927788. PMID 20838484.
Cappellini MD, Taher AT (January 2021). "The use of luspatercept for thalassemia in adults". Blood Advances. 5 (1): 326–333. doi:10.1182/bloodadvances.2020002725. PMC 7805339. PMID 33570654.
Ansari SH, Lassi ZS, Khowaja SM, Adil SO, Shamsi TS, et al. (Cochrane Cystic Fibrosis and Genetic Disorders Group) (March 2019). "Hydroxyurea (hydroxycarbamide) for transfusion-dependent β-thalassaemia". The Cochrane Database of Systematic Reviews. 3 (3): CD012064. doi:10.1002/14651858.CD012064.pub2. PMC 6421980. PMID 30882896.
Bhardwaj A, Swe KM, Sinha NK (May 2023). "Treatment for osteoporosis in people with beta-thalassaemia". The Cochrane Database of Systematic Reviews. 5 (5): CD010429. doi:10.1002/14651858.CD010429.pub3. PMC 10167785. PMID 37159055.
Lucarelli G, Isgrò A, Sodani P, Gaziev J (May 2012). "Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia". Cold Spring Harbor Perspectives in Medicine. 2 (5): a011825. doi:10.1101/cshperspect.a011825. PMC 3331690. PMID 22553502.
Angelucci E, Pilo F, Targhetta C, Pettinau M, Depau C, Cogoni C, et al. (December 2009). "Hematopietic stem cell transplantation in thalassemia and related disorders". Mediterranean Journal of Hematology and Infectious Diseases. 1 (1): e2009015. doi:10.4084/MJHID.2009.015. PMC 3033161. PMID 21415993.
Sodani P, Isgrò A, Gaziev J, Paciaroni K, Marziali M, Simone MD, et al. (June 2011). "T cell-depleted hla-haploidentical stem cell transplantation in thalassemia young patients". Pediatric Reports. 3 Suppl 2 (Suppl 2): e13. doi:10.4081/pr.2011.s2.e13. PMC 3206538. PMID 22053275.
Negre O, Eggimann AV, Beuzard Y, Ribeil JA, Bourget P, Borwornpinyo S, et al. (February 2016). "Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene". Human Gene Therapy. 27 (2): 148–165. doi:10.1089/hum.2016.007. PMC 4779296. PMID 26886832.
Khatri G, Sahito AM, Ansari SA (December 2021). "Shared molecular basis, diagnosis, and co-inheritance of alpha and beta thalassemia". Blood Research. 56 (4): 332–333. doi:10.5045/br.2021.2021128. PMC 8721464. PMID 34776416.
Wambua S, Mwacharo J, Uyoga S, Macharia A, Williams TN (April 2006). "Co-inheritance of alpha+-thalassaemia and sickle trait results in specific effects on haematological parameters". British Journal of Haematology. 133 (2): 206–209. doi:10.1111/j.1365-2141.2006.06006.x. PMC 4394356. PMID 16611313.
Torres L, Okumura JV, Silva DG, Bonini-Domingos CR (March 2015). "Hemoglobin D-Punjab: origin, distribution and laboratory diagnosis". Revista Brasileira De Hematologia E Hemoterapia. 37 (2): 120–126. doi:10.1016/j.bjhh.2015.02.007. PMC 4382585. PMID 25818823.

pmc.ncbi.nlm.nih.gov

Fattoum S (10 November 2009). "Evolution of hemoglobinopathy prevention in Africa: results, problems and prospect". Mediterranean Journal of Hematology and Infectious Diseases. pp. e2009005. doi:10.4084/MJHID.2009.005.
Kattamis A, Forni GL, Aydinok Y, Viprakasit V (December 2020). "Changing patterns in the epidemiology of β-thalassemia". European Journal of Haematology. pp. 692–703. doi:10.1111/ejh.13512.

ghr.nlm.nih.gov

"Beta thalassemia". Genetics Home Reference. Archived from the original on 2015-05-13. Retrieved 2015-05-26.

npr.org

Stein R (31 October 2023). "FDA advisers see no roadblocks for gene-editing treatment for sickle cell disease". NPR. Archived from the original on 4 December 2023. Retrieved 4 December 2023.

omim.org

Online Mendelian Inheritance in Man (OMIM): Hemoglobin—Beta Locus; HBB - 141900

patient.info

Tidy C (23 Feb 2023). "Thalassaemia". Egton Medical Information Systems Limited. Retrieved 2025-01-16.

science.org

Kaiser J (5 December 2020). "CRISPR and another genetic strategy fix cell defects in two common blood disorders". ScienceMag.org. Science. Retrieved 7 December 2020. ... teams report that two strategies for directly fixing malfunctioning blood cells have dramatically improved the health of a handful of people with these genetic diseases.

semanticscholar.org

api.semanticscholar.org

Taher AT, Musallam KM, Cappellini MD (February 2021). "β-Thalassemias". The New England Journal of Medicine. 384 (8): 727–743. doi:10.1056/NEJMra2021838. PMID 33626255. S2CID 232049825.
Leung TN, Lau TK, Chung TK (April 2005). "Thalassaemia screening in pregnancy". Current Opinion in Obstetrics & Gynecology. 17 (2): 129–134. doi:10.1097/01.gco.0000162180.22984.a3. PMID 15758603. S2CID 41877258.

swbh.nhs.uk

"Endocrine Problems in Thalassemia" (PDF). Sandwell and West Birmingham NHS Trust. January 2016.

thalassemia.org

Butler C (16 January 2025). "Transfusion Issues in Thalassemia" (PDF). The Cooley’s Anemia Foundation. Retrieved 16 January 2025.

tufts.edu

perseus.tufts.edu

θάλασσα, αἷμα. Liddell, Henry George; Scott, Robert; A Greek–English Lexicon at the Perseus Project.

ucsf.edu

Leigh S (2018-05-25). "Baby Born in World's First In Utero Stem Cell Transplant Trial | UC San Francisco". University of California San Francisco. Retrieved 2025-01-20.

uptodate.com

Ghidini A (19 March 2024). "Fetal blood sampling". UpToDate, Inc. Retrieved 2025-01-13.

wa.gov

doh.wa.gov

"Hemoglobin C" (PDF). Washington State Department of Health. February 2011.

wales.nhs.uk

111.wales.nhs.uk

"Thalassaemia". Wales Ambulance Service NHS Trust. 25 Oct 2023. Retrieved 8 Jan 2025.

web.archive.org

Advani P. "Beta Thalassemia Treatment & Management". Medscape. Archived from the original on 4 April 2017. Retrieved 4 April 2017.
"Beta thalassemia". Genetics Home Reference. Archived from the original on 2015-05-13. Retrieved 2015-05-26.
McKinney ES, James SR, Murray SS, Nelson K, Ashwill J (2014-04-17). Maternal-Child Nursing. Elsevier Health Sciences. ISBN 978-0-323-29377-8. Archived from the original on 2023-01-14. Retrieved 2020-10-25.
"Beta Thalassemia". Johns Hopkins Medicine. Archived from the original on 2025-01-25. Retrieved 2025-02-18.
Carton J (2012-02-16). Oxford Handbook of Clinical Pathology. OUP Oxford. ISBN 978-0-19-162993-8. Archived from the original on 2023-01-14. Retrieved 2020-10-25.
"MHRA authorises world-first gene therapy that aims to cure sickle-cell disease and transfusion-dependent β-thalassemia". Medicines and Healthcare products Regulatory Agency (MHRA) (Press release). 16 November 2023. Archived from the original on 25 November 2023. Retrieved 8 December 2023.
Introduction to Pathology for the Physical Therapist Assistant. Jones & Bartlett Publishers. 2011. ISBN 978-0-7637-9908-3. Archived from the original on 2023-01-14. Retrieved 2020-10-25.
Leonard DG (2007-11-25). Molecular Pathology in Clinical Practice. Springer. ISBN 978-0-387-33227-7. Archived from the original on 2023-01-14. Retrieved 2020-10-25.
National Organization for Rare Disorders (2003). NORD Guide to Rare Disorders. Lippincott Williams & Wilkins. ISBN 978-0-7817-3063-1. Archived from the original on 2023-01-14. Retrieved 2020-10-25.
Barton JC, Edwards CQ (2000-01-13). Hemochromatosis: Genetics, Pathophysiology, Diagnosis and Treatment. Cambridge University Press. ISBN 978-0-521-59380-9. Archived from the original on 2023-01-14. Retrieved 2020-10-25.
"Risk Factors". Mayo Clinic. Archived from the original on 20 November 2016. Retrieved 4 April 2017.
"MHRA authorises world-first gene therapy that aims to cure sickle-cell disease and transfusion-dependent β-thalassemia". Medicines and Healthcare products Regulatory Agency (MHRA) (Press release). 16 November 2023. Archived from the original on 25 November 2023. Retrieved 8 December 2023.
"Zynteglo". U.S. Food and Drug Administration. 17 August 2022. Archived from the original on 26 August 2022. Retrieved 26 August 2022.
"FDA Approves First Cell-Based Gene Therapy to Treat Adult and Pediatric Patients with Beta-thalassemia Who Require Regular Blood Transfusions". U.S. Food and Drug Administration (FDA) (Press release). 17 August 2022. Archived from the original on 21 August 2022. Retrieved 20 August 2022. This article incorporates text from this source, which is in the public domain.
Stein R (31 October 2023). "FDA advisers see no roadblocks for gene-editing treatment for sickle cell disease". NPR. Archived from the original on 4 December 2023. Retrieved 4 December 2023.
"Patient Information | CASGEVY® (exagamglogene autotemcel)". www.casgevy.com. Archived from the original on 2024-12-02. Retrieved 2025-01-20.
"WHO | Global epidemiology of haemoglobin disorders and derived service indicators". www.who.int. Archived from the original on October 30, 2011. Retrieved 2015-05-26.
Abouelmagd A, Ageely HM (2013). Basic Genetics: A Primer Covering Molecular Composition of Genetic Material, Gene Expression and Genetic Engineering, and Mutations and Human Genetic. Universal-Publishers. ISBN 978-1-61233-192-8. Archived from the original on 2023-01-14. Retrieved 2020-10-25.
Weatherall DJ (2010). "The Thalassemias: Disorders of Globin Synthesis". In Lichtman MA, Kipps TJ, Seligsohn U, Kaushansky K, Prchal JT (eds.). Williams Hematology (8th ed.). The McGraw-Hill Companies. Archived from the original on 2013-11-04. Retrieved 2012-10-02.

who.int

"WHO | Global epidemiology of haemoglobin disorders and derived service indicators". www.who.int. Archived from the original on October 30, 2011. Retrieved 2015-05-26.

worldcat.org

search.worldcat.org

Lippincott Williams & Wilkins (2009). Professional Guide to Diseases. Lippincott Williams & Wilkins. ISBN 978-0-7817-7899-2. OCLC 175284310.
Paulson RF, Hariharan S, Little JA (2020-09-01). "Stress erythropoiesis: definitions and models for its study". Experimental Hematology. 89: 43–54.e2. doi:10.1016/j.exphem.2020.07.011. ISSN 0301-472X. PMC 7508762. PMID 32750404.